Complete response to neoadjuvant chemoradiation therapy for esophageal cancer does not confer a survival advantage

被引:0
作者
C. R. Schmidt
J. L. Tarpley
J. R. Roberts
A. S. Pearson
M. C. Kelley
M. Ninan
J. D. Berlin
A. B. Chakravarthy
R. D. Beauchamp
N. B. Merchant
机构
[1] Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center,
[2] Nashville Veterans Administration Hospital,undefined
来源
Annals of Surgical Oncology | 2004年 / 11卷
关键词
Gemcitabine; Esophageal Cancer; Intraductal Papillary Mucinous Neoplasm; Invasive Adenocarcinoma; Intraductal Papillary Mucinous Neoplasm;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:S55 / S55
相关论文
empty
未找到相关数据